Related Experiment Video
Updated: Jun 27, 2026
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Identification and management of severe respiratory syncytial virus
1Pediatric Cardiac Intensive Care Unit, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, MO 63110, USA. pchecchia@wustl.edu
Insights
Identifying children at risk for severe respiratory syncytial virus (RSV) is crucial for implementing effective management strategies and reducing disease severity. Prevention is key, especially for high-risk infants, as current treatments are supportive and often suboptimal.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Respiratory syncytial virus (RSV) infection presents with a spectrum of illness, from mild cold-like symptoms to severe lower respiratory tract disease.
- Severe RSV disease can manifest with wheezing, chest-wall retractions, cyanosis, and tachypnea, and may include extrapulmonary complications like sepsis-like syndromes and arrhythmias.
- Risk factors for acquiring RSV infection and for developing severe disease have been identified, necessitating careful patient assessment.
Purpose of the Study:
- To discuss the identification of children at risk for severe respiratory syncytial virus (RSV) disease.
- To highlight the importance of implementing appropriate management strategies to reduce morbidity.
- To emphasize the role of risk assessment in clinical decision-making for RSV bronchiolitis.
Main Methods:
- Review of clinical manifestations and risk factors associated with RSV infection.
- Discussion of current management strategies and guidelines, including those from the American Academy of Pediatrics (AAP).
- Evaluation of the effectiveness of supportive care and the importance of prevention.
Main Results:
- RSV infection commonly causes mild upper respiratory tract illness in infants.
- Severe RSV disease involves lower respiratory tract complications and can present with significant respiratory distress and systemic symptoms.
- Risk factors for severe RSV disease are established, guiding clinical evaluation.
Conclusions:
- The American Academy of Pediatrics (AAP) provides guidelines for managing RSV bronchiolitis, but supportive treatments are often suboptimal.
- Prevention strategies are paramount, particularly for high-risk infants, due to limitations in current treatment options.
- Early identification of at-risk children is essential for timely and appropriate management of RSV disease.
Purpose:
Identifying children at risk for severe respiratory syncytial virus (RSV) so that the most appropriate management strategies can be implemented, thereby reducing the morbidity associated with this disease, is discussed.
Summary:
RSV infection is associated with a variety of clinical manifestations, ranging from mild cold-like symptoms to more severe disease. The majority of infants infected with RSV develop mild upper respiratory tract disease during their initial RSV infection. However, more severe RSV disease can occur when the lower respiratory tract becomes involved, with symptoms escalating to include significant wheezing and chest-wall retractions, as well as cyanosis and tachypnea in the most severe cases. Extrapulmonary manifestations of RSV disease also have been observed, such as sepsis-like syndrome and arrhythmias. Factors that increase the risk of acquiring RSV infection have been identified, along with factors that increase the risk of severe RSV disease. The American Academy of Pediatrics (AAP) recommends that clinicians assess risk factors for severe disease when making decisions regarding evaluation and management of children with bronchiolitis. There is currently no curative treatment for RSV infection, and management primarily involves the treatment of specific symptoms. The AAP developed clinical practice guidelines to provide an evidence-based approach to the diagnosis and management of bronchiolitis in children aged one month to two years, with detailed recommendations on which therapies are appropriate for children with more severe RSV disease.
Conclusion:
The AAP developed specific guidelines for the management of RSV bronchiolitis; however, treatment is primarily supportive and has been shown to be suboptimal in many patients. Because of the limitations associated with the management of RSV disease, prevention remains of paramount importance, especially in patients at high risk for severe disease.
More Related Videos
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Acute Respiratory Failure-III
01:31Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.